NASDAQ
NeuroSense Therapeutics Ltd. (NRSN) has a fcf yield of -39.19% as of Friday, May 29, 2026. This represents a 14.84% increase compared to its 12-month average of -46.02%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.